Bebac user
☆    

Egypt,
2025-02-25 21:30
(95 d 23:17 ago)

Posting: # 24376
Views: 876
 

 Question about Williams Design [Design Issues]

Post reply
Hello Dears,

Is this study design acceptable?

## Williams design ##

Three treatments, three phases and six sequences.

T1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.
T2.. Sitagliptin 100mg and Empagliflozin 25mg.
R1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.

Thanks in advance.
 
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
38 visitors (0 registered, 38 guests [including 27 identified bots]).
Forum time: 21:47 CEST (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5